Progyny [PGNY] vs Elevance Health [ELV] Detailed Stock Comparison

Progyny

NASDAQ
Loading...

Elevance Health

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Progyny wins in 6 metrics, Elevance Health wins in 12 metrics, with 0 ties. Elevance Health appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricProgynyElevance HealthBetter
P/E Ratio (TTM)34.9014.86Elevance Health
Price-to-Book Ratio3.411.80Elevance Health
Debt-to-Equity Ratio5.5668.84Progyny
PEG Ratio3.14-0.68Elevance Health
EV/EBITDA18.497.85Elevance Health
Profit Margin (TTM)4.28%2.83%Progyny
Operating Margin (TTM)7.32%5.29%Progyny
EBITDA Margin (TTM)7.32%5.29%Progyny
Return on Equity10.94%12.42%Elevance Health
Return on Assets (TTM)6.57%4.65%Progyny
Free Cash Flow (TTM)$173.70M$4.55BElevance Health
Dividend YieldN/A1.32%N/A
1-Year Return26.32%-28.77%Progyny
Price-to-Sales Ratio (TTM)1.430.42Elevance Health
Enterprise Value$1.49B$74.45BElevance Health
EV/Revenue Ratio1.200.39Elevance Health
Gross Profit Margin (TTM)23.72%N/AN/A
Revenue per Share (TTM)$14$829Elevance Health
Earnings per Share (Diluted)$0.59$23.58Elevance Health
Beta (Stock Volatility)1.340.59Elevance Health
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Progyny vs Elevance Health Stock Performance Analysis

Loading Price Chart...

Progyny
Elevance Health
Progyny Stock Overview | Elevance Health Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Progyny-1.94%-4.05%-12.53%-4.05%-11.06%16.13%
Elevance Health-0.16%10.01%8.99%0.76%-22.57%-4.19%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Progyny26.32%-45.11%-28.73%29.17%29.17%29.17%
Elevance Health-28.77%-24.96%19.05%149.48%537.16%372.37%

News Based Sentiment: Progyny vs Elevance Health

Progyny

News based Sentiment: MIXED

Progyny's Q2 2025 earnings presented a mixed picture, with revenue exceeding expectations but EPS falling short. This creates a somewhat uncertain outlook, making it a moderately important development for investors to consider.

View Progyny News Sentiment Analysis

Elevance Health

News based Sentiment: MIXED

Elevance Health is facing both positive and negative developments this month. While institutional investment and reaffirmed guidance are encouraging, the lawsuit, enrollment declines, and expected earnings decrease create uncertainty. The overall narrative suggests a company navigating challenges while maintaining a reasonably strong position.

View Elevance Health News Sentiment Analysis

Performance & Financial Health Analysis: Progyny vs Elevance Health

MetricPGNYELV
Market Information
Market Cap i$1.79B$78.92B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,040,7921,900,110
90 Day Avg. Volume i1,058,1142,032,487
Last Close$20.19$349.94
52 Week Range$13.39 - $26.76$273.71 - $510.24
% from 52W High-24.55%-31.42%
All-Time High$68.32 (Nov 01, 2021)$567.26 (Sep 02, 2024)
% from All-Time High-70.45%-38.31%
Growth Metrics
Quarterly Revenue Growth0.10%0.14%
Quarterly Earnings Growth0.04%-0.24%
Financial Health
Profit Margin (TTM) i0.04%0.03%
Operating Margin (TTM) i0.07%0.05%
Return on Equity (TTM) i0.11%0.12%
Debt to Equity (MRQ) i5.5668.84
Cash & Liquidity
Book Value per Share (MRQ)$6.04$194.46
Cash per Share (MRQ)$3.55$154.51
Operating Cash Flow (TTM) i$202.00M$6.45B
Levered Free Cash Flow (TTM) i$194.61M$12.05B
Dividends
Last 12-Month Dividend Yield iN/A1.32%
Last 12-Month Dividend iN/A$4.97

Valuation & Enterprise Metrics Analysis: Progyny vs Elevance Health

MetricPGNYELV
Price Ratios
P/E Ratio (TTM) i34.9014.86
Forward P/E i27.0910.03
PEG Ratio i3.14-0.68
Price to Sales (TTM) i1.430.42
Price to Book (MRQ) i3.411.80
Market Capitalization
Market Capitalization i$1.79B$78.92B
Enterprise Value i$1.49B$74.45B
Enterprise Value Metrics
Enterprise to Revenue i1.200.39
Enterprise to EBITDA i18.497.85
Risk & Other Metrics
Beta i1.340.59
Book Value per Share (MRQ) i$6.04$194.46

Financial Statements Comparison: Progyny vs Elevance Health

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PGNYELV
Revenue/Sales i$332.87M$49.78B
Cost of Goods Sold i$253.90MN/A
Gross Profit i$78.97MN/A
Research & Development iN/AN/A
Operating Income (EBIT) i$24.36MN/A
EBITDA i$25.56MN/A
Pre-Tax Income i$27.08M$2.29B
Income Tax i$9.97M$548.00M
Net Income (Profit) i$17.11M$1.74B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PGNYELV
Cash & Equivalents i$109.24M$8.56B
Total Current Assets i$567.69MN/A
Total Current Liabilities i$237.13MN/A
Long-Term Debt i$26.00M$28.18B
Total Shareholders Equity i$467.16M$43.85B
Retained Earnings i$159.37M$35.55B
Property, Plant & Equipment i$42.69MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PGNYELV
Operating Cash Flow i$27.84M$1.77B
Capital Expenditures i$-2.84M$-267.00M
Free Cash Flow i$46.97M$1.79B
Debt Repayment iN/A$110.00M
Common Stock Repurchase i$0$-378.00M

Short Interest & Institutional Ownership Analysis

MetricPGNYELV
Shares Short i6.87M3.68M
Short Ratio i7.441.71
Short % of Float i0.11%0.02%
Average Daily Volume (10 Day) i1,040,7921,900,110
Average Daily Volume (90 Day) i1,058,1142,032,487
Shares Outstanding i85.31M227.48M
Float Shares i79.59M224.66M
% Held by Insiders i0.08%0.00%
% Held by Institutions i1.04%0.93%

Dividend Analysis & Yield Comparison: Progyny vs Elevance Health

MetricPGNYELV
Last 12-Month Dividend iN/A$4.97
Last 12-Month Dividend Yield iN/A1.32%
3-Year Avg Annual Dividend iN/A$5.08
3-Year Avg Dividend Yield iN/A0.32%
3-Year Total Dividends iN/A$15.23
Ex-Dividend DateN/AMar 10, 2025